The purpose of this task order is to support the NIH NCI patent legal services for biotechnology. POP 06/29/2021-06/28/2022.

Ended Awarded Last action

Contract number
75N91021F00156
Awardee
Awarding agency
Obligated
$3,102,866

Award facts

Contract value 100% obligated
$3,102,866.25 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541110 Offices of Lawyers
Set-aside
No set-aside
Competition
Full and Open Competition · 8 offers Multiple Award, Fair Opportunity
Pricing
Time and Materials
Place of performance
Portland, OR 97204, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00006 · 2026 UDO closeout initiative - the purpose of this modification is to deobligate unused funds on this expired time and materials contract in preparation for… -$1,507,796
Funding Only Action P00005 -$770,060
Funding Only Action P00004 -$239,000
Exercise an Option P00003 $1,920,669
Exercise an Option P00002 $1,792,307
Exercise an Option P00001 $487,172
Original award $1,419,574

About this award

The National Cancer Institute issued a delivery order to Klarquist Sparkman, LLP on June 29, 2021, with a ceiling value of $3,102,866.25 for patent legal services supporting NIH NCI biotechnology patents. The order was issued under the NIH Patent Legal Services parent IDIQ and carried a time-and-materials pricing structure. Ultimate completion occurred on June 28, 2024.

Place of performance is Portland, OR. The order supported patent legal services including prosecution, filing, and technology transfer for biotechnology-related inventions arising from federally funded research.

Service Contract Inventory reporting shows government-invoiced labor of $46,000 in FY2021 (63 contractor hours), $1.1 million in FY2022 (1,331 hours, 0.6 FTEs), $841,000 in FY2023 (1,286 hours, 0.6 FTEs), and $967,000 in FY2024 (1,240 hours, 0.6 FTEs). Derived government-paid hourly rates ranged from $654.10 in FY2023 to $850.75 in FY2022. Klarquist Sparkman self-performed all work with no subcontractors reported. This order is currently subject to administrative closeout under the 2026 Undisbursed Delivery Order Closeout Initiative.

Quick answers

Who was awarded contract 75N91021F00156?

75N91021F00156 was awarded to Klarquist Sparkman, LLP by National Cancer Institute (National Institutes of Health) on June 29, 2021.

How much is contract 75N91021F00156 worth?

The government has obligated $3,102,866 on 75N91021F00156.

Is contract 75N91021F00156 an order under another contract?

Yes. 75N91021F00156 is a delivery order under 75N98020D00049, an indefinite delivery contract, on NIH Patent Legal Services.

Was contract 75N91021F00156 competed?

The extent of competition for 75N91021F00156 was full and open competition. The government received 8 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award